Device type · QJQ
Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QJQ
Neurology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety
- Product code
- QJQ
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5800
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for QJQ
Latest FDA decisions
- Genesis Sleep510(k)
K252951 · Decided Dec 31, 2025 · 106 days after receipt
Device type: Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety (QJQ) · Neurology & Neurosurgery
- Modius Stress510(k)
K232253 · Decided Mar 27, 2024 · 243 days after receipt
Device type: Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety (QJQ) · Neurology & Neurosurgery
- Modius Sleep510(k)
K230826 · Decided Oct 27, 2023 · 217 days after receipt
Device type: Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety (QJQ) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Fisher Wallace Stimulator Models FW-100 and FW-200Open, Classified
Fisher Wallace Laboratories Inc.
Z-1600-2023 · Started Apr 6, 2023 · Posted by FDA May 17, 2023
Reason given: If the batteries are installed incorrectly, the product may overheat, possibly leading to pain, discomfort, irritation, or even burns during use of the device.
Cause as FDA categorized it: Nonconforming Material/Component
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.